Eagle Health Investments LP - Q2 2022 holdings

$429 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 57.1% .

 Value Shares↓ Weighting
AZN SellASTRAZENECA PLCsponsored adr$25,309,000
-14.4%
383,065
-14.0%
5.90%
-19.0%
ARGX SellARGENX SEsponsored adr$22,846,000
+3.7%
60,300
-13.7%
5.33%
-1.9%
AMWL SellAMERICAN WELL CORPcl a$16,163,000
+0.7%
3,741,413
-1.8%
3.77%
-4.7%
CCCC ExitC4 THERAPEUTICS INC$0-47,200
-100.0%
-0.28%
KYMR ExitKYMERA THERAPEUTICS INC$0-37,000
-100.0%
-0.39%
MRTX ExitMIRATI THERAPEUTICS INC$0-52,000
-100.0%
-1.05%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-82,144
-100.0%
-5.28%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings